Quarterly report pursuant to sections 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Textual)

v2.4.0.6
COMMITMENTS AND CONTINGENCIES (Details Textual) (USD $)
 0 Months Ended 3 Months Ended 9 Months Ended 125 Months Ended 0 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended
Apr. 04, 2011
Jul. 31, 2012
Jul. 31, 2011
Jul. 31, 2012
Jul. 31, 2011
Jul. 31, 2012
Jul. 24, 2012
Jun. 13, 2012
May 31, 2012
Dec. 12, 2011
Oct. 31, 2011
May 10, 2010
Pennsylvania [Member]
Jul. 31, 2012
Pennsylvania [Member]
Jul. 31, 2012
Pharm Olam International [Member]
May 10, 2010
Numoda [Member]
Jul. 31, 2012
Numoda [Member]
Jun. 13, 2012
Numoda [Member]
Jul. 31, 2012
Socius [Member]
Option Exercise Fee Payable                   $ 20,000.00   $ 35,000   $ 223,620        
Stock Issued During Period, Value, New Issues                       70,000            
Stock Issued During Period, Shares, New Issues   2,500,000                   388,889            
Stock Price:   $ 0.148   $ 0.148   $ 0.148   $ 0.15       $ 0.18         $ 0.15  
Licenses Revenue                         507,000          
Research & Development Expenses   1,331,415 1,958,518 5,760,158 6,392,919 28,916,898               12,200,000        
Stock Issued During Period, Value, Issued for Services                             350,000      
Stock Issued During Period, Shares, Issued for Services                             3,500,000      
Payments of Distributions to Affiliates                               7,400,000    
Payments for Leasing Costs 15,600                                  
Cost of Utilities 7,200                                  
Cost Of Utilities Per R E $ 10,700                                  
Expected Lease Operating Expenses 288,000                                  
Operating Leases, Rent Expense       19,200                            
Common stock, shares issued   375,135,008   375,135,008   375,135,008 11,111,000   4,000,000   250,173,570           15,000,000  
Accounts Payable                                 1,700,000  
Non Cash Income             968,000 869,000                   444,000
Claims Payable             2,888,860                 18,000,000   1,800,000
Related Party Transaction, Amounts of Transaction                               1,000,000    
Accounts Receivable, Net                                 $ 2,250,000